中国人工器官和仿生植入物市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

中国人造器官和仿生植入物市场按类型细分(人造器官、仿生学)

市场快照

CAGR
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 11.69 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计中国人造器官和仿生植入物市场在预测期内将以 11.69% 的复合年增长率增长。该国市场的增长可归因于随着老年人口的增加,残疾和器官衰竭的发病率不断增加。此外,技术进步也推动了市场增长。

根据国家心血管病中心的数据,2017年,中国心血管病患者约2.9亿。此外,老年人口的增加和心律失常、中风和高血压等心血管疾病发病率的增加,也推动了市场对心脏仿生学的需求。

然而,器官和程序的高成本是主要制约因素。此外,对设备故障及其后果的恐惧,以及执行该程序的专家有限,也限制了中国人造器官和仿生植入物市场的增长。

Scope of the report

As per the scope of the report, artificial organs and bionics are man-made devices that can be implanted or integrated in humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to return to his normal life.

By Product
Artificial Organs
Artificial Heart
Artificial Kidney
Others
Bionics
Vision Bionics
Ear Bionics
Orthopedic Bionic
Cardiac Bionics
Others

Report scope can be customized per your requirements. Click here.

主要市场趋势

骨科板块预计在预测期内有较高的增长率

该细分市场的预期增长归因于道路事故和需要截肢的伤害数量的增加。根据中国国家统计局的数据,2018年全国交通事故死亡人数为63194人。广东和湖北是交通死亡人数最多的省份,均位于中国东部沿海地区,他们也是2018年交通事故最多的地区。除了交通事故和伤害,另一个导致截肢的情况是该地区糖尿病的高发病率。因此,越来越多的截肢以及交通事故和糖尿病等原因正在推动市场的增长。

china accidents

竞争格局

中国人工器官和仿生植入物市场与几家主要参与者竞争适度。实施的一些战略包括协议、协作模式、业务扩展和产品开发。一些主要的公司包括 Ossur、波士顿科学公司、Otto Bock Holding GmbH & Co. KG、美敦力 plc 和 Zimmer Biomet。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Disabilities and Organ Failures with the Rising Geriatric Population

      2. 4.2.2 Technological Advancements Leading to Enhanced Applications

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Procedures and Fear of Device Malfunction and its Consequences

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Artificial Organs

        1. 5.1.1.1 Artificial Heart

        2. 5.1.1.2 Artificial Kidney

        3. 5.1.1.3 Others

      2. 5.1.2 Bionics

        1. 5.1.2.1 Vision Bionics

        2. 5.1.2.2 Ear Bionics

        3. 5.1.2.3 Orthopedic Bionic

        4. 5.1.2.4 Cardiac Bionics

        5. 5.1.2.5 Others

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Ossur

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Otto Bock Holding GmbH & Co. KG

      4. 6.1.4 Medtronic plc

      5. 6.1.5 Zimmer Biomet

      6. 6.1.6 Getinge AB

      7. 6.1.7 Sonova Holding AG (Advanced Bionics)

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The China Artificial Organs & Bionic Implants Market market is studied from 2018 - 2026.

The China Artificial Organs & Bionic Implants Market is growing at a CAGR of 11.69% over the next 5 years.

Zimmer Biomet, Boston Scientific Corporation, Medtronic Inc., Otto Bock Holding GmbH & Co. KG, Ossur are the major companies operating in China Artificial Organs & Bionic Implants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!